167 related articles for article (PubMed ID: 11172734)
1. Apoptotic response of HL-60 human leukemia cells to the antitumor drug NB-506, a glycosylated indolocarbazole inhibitor of topoisomerase 1.
Facompre M; Goossens JF; Bailly C
Biochem Pharmacol; 2001 Feb; 61(3):299-310. PubMed ID: 11172734
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103.
Kluza J; Lansiaux A; Wattez N; Mahieu C; Osheroff N; Bailly C
Cancer Res; 2000 Aug; 60(15):4077-84. PubMed ID: 10945613
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells.
Lansiaux A; Facompré M; Wattez N; Hildebrand MP; Bal C; Demarquay D; Lavergne O; Bigg DC; Bailly C
Mol Pharmacol; 2001 Sep; 60(3):450-61. PubMed ID: 11502875
[TBL] [Abstract][Full Text] [Related]
4. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
5. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells.
Lansiaux A; Laine W; Baldeyrou B; Mahieu C; Wattez N; Vezin H; Martinez FJ; Piñeyro A; Bailly C
Chem Res Toxicol; 2001 Jan; 14(1):16-24. PubMed ID: 11170504
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of mahanine-induced apoptosis in human leukemia cells (HL-60).
Roy MK; Thalang VN; Trakoontivakorn G; Nakahara K
Biochem Pharmacol; 2004 Jan; 67(1):41-51. PubMed ID: 14667927
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
[TBL] [Abstract][Full Text] [Related]
9. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
10. Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.
Vanhoefer U; Voigt W; Hilger RA; Yin MB; Harstrick A; Seeber S; Rustum YM
Oncol Res; 1997; 9(9):485-94. PubMed ID: 9495454
[TBL] [Abstract][Full Text] [Related]
11. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
[TBL] [Abstract][Full Text] [Related]
12. Sequence-selective DNA cleavage by a topoisomerase I poison, NB-506.
Fukasawa K; Komatani H; Hara Y; Suda H; Okura A; Nishimura S; Yoshinari T
Int J Cancer; 1998 Jan; 75(1):145-50. PubMed ID: 9426703
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of Poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis.
Li X; Darzynkiewicz Z
Exp Cell Res; 2000 Feb; 255(1):125-32. PubMed ID: 10666341
[TBL] [Abstract][Full Text] [Related]
14. Cholesteryl-hemisuccinate-induced apoptosis of promyelocytic leukemia HL-60 cells through a cyclosporin A-insensitive mechanism.
Yamada K; Arita K; Kobuchi H; Yamamoto S; Yoshioka T; Tamai H; Utsumi K
Biochem Pharmacol; 2003 Feb; 65(3):339-48. PubMed ID: 12527327
[TBL] [Abstract][Full Text] [Related]
15. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
16. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease.
Lee WR; Shen SC; Lin HY; Hou WC; Yang LL; Chen YC
Biochem Pharmacol; 2002 Jan; 63(2):225-36. PubMed ID: 11841797
[TBL] [Abstract][Full Text] [Related]
17. Induction of G2/M phase arrest and apoptosis of human leukemia cells by potent antitumor triazoloacridinone C-1305.
Augustin E; Moś-Rompa A; Skwarska A; Witkowski JM; Konopa J
Biochem Pharmacol; 2006 Dec; 72(12):1668-79. PubMed ID: 16970926
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activities of a new indolocarbazole substance, NB-506, and establishment of NB-506-resistant cell lines, SBC-3/NB.
Kanzawa F; Nishio K; Kubota N; Saijo N
Cancer Res; 1995 Jul; 55(13):2806-13. PubMed ID: 7796407
[TBL] [Abstract][Full Text] [Related]
19. Magnolol induces apoptosis in human leukemia cells via cytochrome c release and caspase activation.
Zhong WB; Wang CY; Ho KJ; Lu FJ; Chang TC; Lee WS
Anticancer Drugs; 2003 Mar; 14(3):211-7. PubMed ID: 12634615
[TBL] [Abstract][Full Text] [Related]
20. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin.
Huang X; Okafuji M; Traganos F; Luther E; Holden E; Darzynkiewicz Z
Cytometry A; 2004 Apr; 58(2):99-110. PubMed ID: 15057963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
